Skip to main content

Publisher: Wiley-Blackwell

Volume 13, Number 11, 1 November 2011

Glucagon antagonism as a potential therapeutic target in type 2 diabetes
pp. 965-971(7)
Authors: Bagger, J. I.; Knop, F. K.; Holst, J. J.; Vilsbøll, T.

Favourites:
ADD
Favourites:
ADD

GLP‐1 signals via ERK in peripheral nerve and prevents nerve dysfunction in diabetic mice
pp. 990-1000(11)
Authors: Jolivalt, C. G.; Fineman, M.; Deacon, C. F.; Carr, R. D.; Calcutt, N. A.

Favourites:
ADD

Short‐term metabolic effects of prednisone administration in healthy subjects
pp. 1001-1007(7)
Authors: Kauh, E. A.; Mixson, L. A.; Shankar, S.; McCarthy, J.; Maridakis, V.; Morrow, L.; Heinemann, L.; Ruddy, M. K.; Herman, G. A.; Kelley, D. E.; Hompesch, M.

Favourites:
ADD

A randomized, parallel group, double‐blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long‐term glycaemic control and bone mineral density after 80 weeks of treatment in drug‐na
pp. 1036-1046(11)
Authors: Borges, J. L. C.; Bilezikian, J. P.; Jones‐Leone, A. R.; Acusta, A. P.; Ambery, P. D.; Nino, A. J.; Grosse, M.; Fitzpatrick, L. A.; Cobitz, A. R.

Favourites:
ADD

Effects of a long‐acting GLP‐1 mimetic (PF‐04603629) on pulse rate and diastolic blood pressure in patients with type 2 diabetes mellitus
pp. 1056-1058(3)
Authors: Gustavson, S. M.; Chen, D.; Somayaji, V.; Hudson, K.; Baltrukonis, D. J.; Singh, J.; Boyden, T. L.; Calle, R. A.

Favourites:
ADD

News and views
pp. 1059-1061(3)
Author: Idris, Iskandar

Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more